Search
News Chat
Login
Search
Top
For You
Business
Crypto
Culture
Environment
Politics
Science
Sports
Tech
Video Games
World
Acadia Pharmaceuticals News
ACAD
ACADIA PHARMACEUTICALS INC
16.04
-1.29%
ACAD
ACADIA PHARMACEUTICALS INC
16.04
-1.29%
Top stories
Neurogene Doses First Patient in High-Dose Cohort for Gene Therapy in Rett Syndrome
Authors
4
14 days
Economics
Business
Articles
Latest stories
Neurogene Doses First Patient in High-Dose Cohort for Gene Therapy in Rett Syndrome
Authors
4
14 days
Economics
Business
Acadia Pharmaceuticals Halts Nuplazid Antipsychotic Drug Trials After Schizophrenia Study Failure
Authors
5
4 months
Bio
Crime
Science
Acadia's Stock Falls 15% After Schizophrenia Drug Fails Phase 3 Trial
Authors
8
4 months
Bio
Crime
Science
Previous
Next